NBP256187PE

Novus Biologicals™ GALNT14 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP256187PE-Each-of-1 In Stock ₹ 31,372.50

NBP256187PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

79623

Common Name

GALNT14 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

EC 2.4.1.41, FLJ12691, FLJ13977, GalNac-T10, GalNac-T14, GALNT15, Polypeptide GalNAc transferase 14, polypeptide N-acetylgalactosaminyltransferase 14, polypeptide N-acetylgalactosaminyltransferase 15, pp-GaNTase 14, Protein-UDP acetylgalactosaminyltransfe

Label Type

Unlabeled

Quantity

100μL

Source

E.Coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

GALNT14

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51181. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP255959PE

--

Img

Novus Biologicals™

NBP256242PE

--

Img

Novus Biologicals™

NBP255364PE

--

Img

Novus Biologicals™

NBP255274PE

--

Img

Novus Biologicals™

NBP255743PE

--

Img

Novus Biologicals™

NBP255688PE

--

Img

Novus Biologicals™

NBP256268PE

--

Img

Novus Biologicals™

NBP255993PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human GALNT14
  • Source: E.coli Amino Acid Sequence: IREIILVDDFSNDPDDCKQLIKLPKVKCLRNNERQGLVRSRIRGADIAQGTTLTFLDSHCEVNRDWLQPLLHRVKEDYTRVVCPVIDIINLDTFTYIESASELRGGFDWSLHFQWEQL The GALNT14 Recombinant Protein Antigen is derived from E
  • coli
  • The GALNT14 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.